BioCentury | Apr 15, 2013
Clinical News

Sibia regulatory update

...events in cells, such as modulation of ion channels, after a test compound is added. Sibia Neurosciences Inc....
BioCentury | Apr 15, 2013
Company News

Neurocrine, Sibia deal

...and enzyme targets associated with nervous system disorders. Neurocrine Biosciences Inc. (NBIX), San Diego, Calif. Sibia Neurosciences Inc....
BioCentury | May 7, 2001
Finance

Measuring neuro progress

...marketed products; acquired Roberts in 1999, in process of merging with BioChem Pharma (BCHE: TSE:BCH) Sibia...
BioCentury | Nov 13, 2000
Company News

Cadus Pharmaceutical Corp., Merck enabling technology news

...of California granted final judgement for KDUS in a 1996 patent infringement suit filed by Sibia Neurosciences Inc....
BioCentury | Oct 16, 2000
Company News

Neurotrophic board of directors update

...Neurotrophic Bioscience Inc., Toronto, Ontario Business: Neurological Appointed: William Comer, former president and CEO of Sibia...
BioCentury | Sep 11, 2000
Strategy

Assay ruling brings a sigh of relief

...court last week overturned a jury verdict in a 1996 patent infringement suit filed by Sibia Neurosciences Inc....
...The victory was Pyrrhic for Sibia, as the protracted dispute proved fatal for both companies. Sibia...
...with Sibia. But OSIP also covered itself by completed a cross-licensing agreement with MRK for Sibia's...
BioCentury | Sep 11, 2000
Company News

Cadus Pharmaceutical Corp., Merck & Co. enabling technology news

...Federal Circuit overturned a 1998 lower court judgement in a patent infringement suit filed by Sibia Neurosciences Inc....
...the Southern District of California ordered KDUS to pay $18 million in damages for infringing Sibia's...
BioCentury | Sep 7, 2000
Company News

Cadus wins on appeal

...in favor of KDUS, overturning a 1998 judgement in a patent infringement suit filed by Sibia...
...in 1999. In 1998, the U.S. District Court for the Southern District of California upheld Sibia's...
...infringement claims against KDUS and required KDUS to pay $18 million in damages for infringing Sibia's...
BioCentury | Aug 7, 2000
Company News

Nereus management update

...Cancer, Autoimmune/Inflammation, Infectious diseases Hired: G. Kenneth Lloyd as CSO, formerly VP of biology at Sibia Neurosciences Inc....
BioCentury | Jun 19, 2000
Strategy

Finding freedom in the debris

...The to-the-death patent saga of Sibia Neuroscience Inc. and Cadus Pharmaceuticals Corp. should have been a...
...ensure the freedom to operate. Indeed, neither company came out a winner - the battle-fatigued Sibia...
...it's just smart business. The litigation between Sibia and Cadus cost Cadus its existence, but Sibia...
Items per page:
1 - 10 of 102
BioCentury | Apr 15, 2013
Clinical News

Sibia regulatory update

...events in cells, such as modulation of ion channels, after a test compound is added. Sibia Neurosciences Inc....
BioCentury | Apr 15, 2013
Company News

Neurocrine, Sibia deal

...and enzyme targets associated with nervous system disorders. Neurocrine Biosciences Inc. (NBIX), San Diego, Calif. Sibia Neurosciences Inc....
BioCentury | May 7, 2001
Finance

Measuring neuro progress

...marketed products; acquired Roberts in 1999, in process of merging with BioChem Pharma (BCHE: TSE:BCH) Sibia...
BioCentury | Nov 13, 2000
Company News

Cadus Pharmaceutical Corp., Merck enabling technology news

...of California granted final judgement for KDUS in a 1996 patent infringement suit filed by Sibia Neurosciences Inc....
BioCentury | Oct 16, 2000
Company News

Neurotrophic board of directors update

...Neurotrophic Bioscience Inc., Toronto, Ontario Business: Neurological Appointed: William Comer, former president and CEO of Sibia...
BioCentury | Sep 11, 2000
Strategy

Assay ruling brings a sigh of relief

...court last week overturned a jury verdict in a 1996 patent infringement suit filed by Sibia Neurosciences Inc....
...The victory was Pyrrhic for Sibia, as the protracted dispute proved fatal for both companies. Sibia...
...with Sibia. But OSIP also covered itself by completed a cross-licensing agreement with MRK for Sibia's...
BioCentury | Sep 11, 2000
Company News

Cadus Pharmaceutical Corp., Merck & Co. enabling technology news

...Federal Circuit overturned a 1998 lower court judgement in a patent infringement suit filed by Sibia Neurosciences Inc....
...the Southern District of California ordered KDUS to pay $18 million in damages for infringing Sibia's...
BioCentury | Sep 7, 2000
Company News

Cadus wins on appeal

...in favor of KDUS, overturning a 1998 judgement in a patent infringement suit filed by Sibia...
...in 1999. In 1998, the U.S. District Court for the Southern District of California upheld Sibia's...
...infringement claims against KDUS and required KDUS to pay $18 million in damages for infringing Sibia's...
BioCentury | Aug 7, 2000
Company News

Nereus management update

...Cancer, Autoimmune/Inflammation, Infectious diseases Hired: G. Kenneth Lloyd as CSO, formerly VP of biology at Sibia Neurosciences Inc....
BioCentury | Jun 19, 2000
Strategy

Finding freedom in the debris

...The to-the-death patent saga of Sibia Neuroscience Inc. and Cadus Pharmaceuticals Corp. should have been a...
...ensure the freedom to operate. Indeed, neither company came out a winner - the battle-fatigued Sibia...
...it's just smart business. The litigation between Sibia and Cadus cost Cadus its existence, but Sibia...
Items per page:
1 - 10 of 102